Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed COO
Inv. presentation
|
|
ATOSSA THERAPEUTICS, INC. (ATOS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/05/2023 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 125,000 options to buy
@ $0.662, valued at
$82.8k
|
|
| 05/05/2023 |
4
| Remmel H. Lawrence (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 125,000 options to buy
@ $0.662, valued at
$82.8k
|
|
| 05/05/2023 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 125,000 options to buy
@ $0.662, valued at
$82.8k
|
|
| 05/05/2023 |
4
| Chen Shu-Chih (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 125,000 options to buy
@ $0.662, valued at
$82.8k
|
|
| 05/05/2023 |
4
| Galli Stephen J (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 125,000 options to buy
@ $0.662, valued at
$82.8k
|
|
| 03/06/2023 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 1,873,100 options to buy
@ $0.72, valued at
$1.3M
|
|
| 03/06/2023 |
4
| Guse Kyle (CFO, Gen Counsel and Secretary) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 557,900 options to buy
@ $0.72, valued at
$401.7k
|
|
| 05/16/2022 |
4
| Chen Shu-Chih (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.93, valued at
$46.5k
|
|
| 05/16/2022 |
4
| Galli Stephen J (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.93, valued at
$46.5k
|
|
| 05/16/2022 |
4
| Remmel H. Lawrence (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.93, valued at
$46.5k
|
|
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Guse Kyle (CFO, Gen Counsel and Secretary) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 746,667 options to buy
@ $1.25, valued at
$933.3k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Galli Stephen J (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $2.9, valued at
$145k
|
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Guse Kyle (CFO, Gen Counsel and Secretary) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 850,000 options to buy
@ $2.9, valued at
$2.5M
|
|
| 05/18/2021 |
4
| Chen Shu-Chih (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $2.9, valued at
$145k
|
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Remmel H. Lawrence (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $2.9, valued at
$145k
|
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2020 |
4
| Remmel H. Lawrence (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 45,000 options to buy
@ $1.7, valued at
$76.5k
|
|
| 05/19/2020 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 70,000 options to buy
@ $1.7, valued at
$119k
|
|
| 05/19/2020 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 45,000 options to buy
@ $1.7, valued at
$76.5k
|
|
| 05/19/2020 |
4
| Chen Shu-Chih (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 45,000 options to buy
@ $1.7, valued at
$76.5k
|
|
| 05/19/2020 |
4
| Galli Stephen J (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 45,000 options to buy
@ $1.7, valued at
$76.5k
|
|
| 04/13/2020 |
4
| Guse Kyle (CFO, Gen Counsel and Secretary) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 195,000 options to buy
@ $1.48, valued at
$288.6k
Granted 395,000 options to buy
@ $1.48, valued at
$584.6k
|
|
| 04/13/2020 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 195,000 options to buy
@ $1.48, valued at
$288.6k
Granted 1,305,000 options to buy
@ $1.48, valued at
$1.9M
|
|
| 05/21/2019 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 45,000 options to buy
@ $2.52, valued at
$113.4k
|
|
| 05/21/2019 |
4
| Steinhart Richard I (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 45,000 options to buy
@ $2.52, valued at
$113.4k
|
|
| 05/21/2019 |
4
| Galli Stephen J (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 45,000 options to buy
@ $2.52, valued at
$113.4k
|
|
| 05/21/2019 |
4
| Remmel H. Lawrence (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 45,000 options to buy
@ $2.52, valued at
$113.4k
|
|
|
|
|